Immunological challenges of cardiac transplantation: The need for better animal models to answer current clinical questions

Journal of Clinical Immunology

Volumn 29, Issue 6, 2009, Pages 722-729

  Wehner, Jennifer R ^a   Morrell, Craig N ^b   Rene Rodriguez, E ^c   Fairchild, Robert L ^c   Baldwin III, William M ^a,c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Antibody mediated rejection; Arteriopathy; C4d; Cardiac transplantation

Indexed keywords

ANTIBODY;

CHRONIC GRAFT ARTERIOPATHY; CLINICAL STUDY; DISEASE MODEL; HEART TRANSPLANTATION; HUMAN; IMMUNOLOGY; KIDNEY GRAFT REJECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; VASCULAR DISEASE;

ANIMALS; COMPLEMENT ACTIVATION; DISEASE MODELS, ANIMAL; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNITY, HUMORAL; MICE; TRANSPLANTATION IMMUNOLOGY;

EID: 72849122717     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-009-9334-4     Document Type: Review

References (55)

1. RE Billingham L Brent PB Medawar 1953 Actively acquired tolerance of foreign cells Nature 172 4379 603 606 10.1038/172603a0 13099277 1:STN:280:DyaG2c%2FitVSqsg%3D%3D
2. JF Borel J Meszaros 1980 Skin transplantation in mice and dogs. Effect of cyclosporin A and dihydrocyclosporin C Transplantation 29 2 161 162 6986689 1:CAS:528:DyaL3cXovVSqsA%3D%3D
3. EM Tuzcu SR Kapadia R Sachar KM Ziada TD Crowe J Feng, et al. 2005 Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation J Am Coll Cardiol 45 9 1538 1542 10.1016/j.jacc.2004.12. 076 15862431 (Pubitemid 40615631)
4. LC Racusen RB Colvin K Solez MJ Mihatsch PF Halloran PM Campbell, et al. 2003 Antibody-mediated rejection criteria-an addition to the banff 97 classification of renal allograft rejection Am J Transplant 3 6 708 714 10.1034/j.1600-6143.2003.00072.x 12780562 (Pubitemid 36745243)
5. M Mengel J Bogers JL Bosmans D Seron F Moreso M Carrera, et al. 2005 Incidence of C4d stain in protocol biopsies from renal allografts: results from a multicenter trial Am J Transplant 5 5 1050 1056 10.1111/j.1600-6143.2005. 00788.x 15816885 (Pubitemid 40571253)
6. S Mauiyyedi RB Colvin 2002 Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment Curr Opin Nephrol Hypertens 11 6 609 618 10.1097/00041552-200211000-00007 12394606 (Pubitemid 35440842)
7. M Haas MH Rahman LC Racusen ES Kraus SM Bagnasco DL Segev, et al. 2006 C4d and C3d staining in biopsies of ABO-and HLA-incompatible renal allografts: correlation with histologic findings Am J Transplant 6 8 1829 1840 10.1111/j.1600-6143.2006.01356.x 16889542 1:CAS:528:DC%2BD28XoslCntb4%3D (Pubitemid 44024954)
8. MG Crespo-Leiro A Veiga-Barreiro N Domenech MJ Paniagua P Pinon M Gonzalez-Cuesta, et al. 2005 Humoral heart rejection (severe allograft dysfunction with no signs of cellular rejection or ischemia): incidence, management, and the value of C4d for diagnosis Am J Transplant 5 10 2560 2564 10.1111/j.1600-6143.2005.01039.x 16162208 1:CAS:528:DC%2BD2MXhtFeqsLrJ (Pubitemid 43919443)
9. ER Rodriguez DV Skojec CD Tan AA Zachary EK Kasper JV Conte, et al. 2005 Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers Am J Transplant 5 11 2778 2785 10.1111/j.1600-6143.2005.01074.x 16212640 1:STN:280:DC%2BD2Mrjslersw%3D%3D (Pubitemid 43920074)
10. RN Smith N Brousaides L Grazette S Saidman M Semigran T Disalvo, et al. 2005 C4d deposition in cardiac allografts correlates with alloantibody J Heart Lung Transplant 24 1202 1210 10.1016/j.healun.2004.07.021 16143234 (Pubitemid 41247799)
11. CD Tan GG Sokos DJ Pidwell NG Smedira GV Gonzalez-Stawinski DO Taylor, et al. 2009 Correlation of donor-specific antibodies, complement and its regulators with graft dysfunction in cardiac antibody-mediated rejection Am J Transplant 9 9 2075 2084 10.1111/j.1600-6143.2009.02748.x 19624562 1:CAS:528:DC%2BD1MXht1ansrnN
12. K Minami K Murata C-Y Lee K Fox-Talbot B Wasowska M Pescovitz, et al. 2006 C4d deposition and clearance in cardiac transplants correlates with alloantibody levels and rejection in rats Am J Transplant 6 5 923 932 10.1111/j.1600-6143.2006.01281.x 16611328 1:CAS:528:DC%2BD28XkvF2gtr0%3D (Pubitemid 44356642)
13. JL Platt 2002 C4d and the Fate of Organ Allografts J Am Soc Nephrol 13 2417 2419 10.1097/01.ASN.0000030140.74450.0B 12191987 (Pubitemid 34925253)
14. WM Baldwin III EK Kasper AA Zachary BA Wasowska ER Rodriguez 2004 Beyond C4d: other complement related diagnostic approaches to antibody-mediated rejection Am J Transplant 4 311 318 10.1111/j.1600-6143.2004.00348.x 14961982 1:CAS:528:DC%2BD2cXivVyhtrg%3D (Pubitemid 38282285)
15. EA Lidington DO Haskard JC Mason 2000 Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement-mediated injury Blood 96 8 2784 2792 11023512 1:CAS:528:DC%2BD3cXnt12gtr8%3D
16. JC Mason H Yarwood K Sugars BP Morgan KA Davies DO Haskard 1999 Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition Blood 94 5 1673 1682 10477692 1:CAS:528:DyaK1MXmtVahsrk%3D
17. JC Mason R Steinberg EA Lidington AR Kinderlerer M Ohba DO Haskard 2004 Decay-accelerating factor induction on vascular endothelium by vascular endothelial growth factor (VEGF) is mediated via a VEGF receptor-2 (VEGF-R2)- and protein kinase C-alpha/epsilon (PKCalpha/epsilon)-dependent cytoprotective signaling pathway and is inhibited by cyclosporin A J Biol Chem 279 40 41611 41618 10.1074/jbc.M407981200 15284224 1:CAS:528:DC%2BD2cXnvFWgsLw%3D (Pubitemid 39313604)
18. H Bian EF Reed 1999 Alloantibody-mediated class I signal transduction in endothelial cells and smooth muscle cells: enhancement by IFN-gamma and TNF-alpha J Immunol 163 2 1010 1018 10395699 1:CAS:528:DyaK1MXksVens70%3D
19. M Yamakuchi NC Kirkiles-Smith M Ferlito SJ Cameron C Bao K Fox-Talbot, et al. 2007 Antibody to human leukocyte antigen triggers endothelial exocytosis Proc Natl Acad Sci U S A 104 4 1301 1306 10.1073/pnas.0602035104 17229850 1:CAS:528:DC%2BD2sXht12isb4%3D (Pubitemid 46183999)
20. PT Jindra YP Jin E Rozengurt EF Reed 2008 HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway J Immunol 180 4 2357 2366 18250445 1:CAS:528:DC%2BD1cXhsVShu74%3D
21. C-Y Lee M Reynolds J Garyu WM Baldwin III BA Wasowska 2007 The involvement of FcR mechanisms in antibody-mediated rejection Transplantation 84 1324 1334 10.1097/01.tp.0000287457.54761.53 18049118 1:CAS:528: DC%2BD2sXhsVygtrnE (Pubitemid 351339321)
22. LR Benzaquen A Nicholson-Weller JA Halperin 1994 Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells J Exp Med 179 985 992 10.1084/jem.179.3.985 8113689 1:CAS:528:DyaK2cXhs1WitbY%3D
23. R Hattori KK Hamilton RP McEver PJ Sims 1989 Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface J Biol Chem 264 15 9053 9060 2470750 1:CAS:528:DyaL1MXktVGmurk%3D
24. CN Morrell K Murata AM Swaim E Mason TV Martin LE Thompson, et al. 2008 In vivo platelet-endothelial cell interactions in response to major histocompatibility complex alloantibody Circ Res 102 7 777 785 10.1161/CIRCRESAHA.107.170332 18296616 1:CAS:528:DC%2BD1cXktV2ksro%3D
25. PW Dempsey ME Allison S Akkaraju CC Goodnow DT Fearon 1996 C3d of complement as a molecular adjuvant: bridging innate and acquired immunity Science New York, NY 271 5247 348 350 1:CAS:528:DyaK28XlsFarsQ%3D%3D
26. Y Kaneko F Nimmerjahn JV Ravetch 2006 Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation Science New York, NY 313 5787 670 673 1:CAS:528:DC%2BD28Xnsl2hsbY%3D
27. H Wang J Jiang W Liu D Kubelik G Chen D Gies, et al. 2005 Prevention of acute vascular rejection by a functionally blocking anti-C5 monoclonal antibody combined with cyclosporine Transplantation 79 9 1121 1127 10.1097/01.TP. 0000161218.58276.9A 15880054 1:CAS:528:DC%2BD2MXjvF2htLw%3D (Pubitemid 40664008)
28. H Wang J Arp W Liu SJ Faas J Jiang DR Gies, et al. 2007 Inhibition of terminal complement components in presensitized transplant recipients prevents antibody-mediated rejection leading to long-term graft survival and accommodation J Immunol 179 7 4451 4463 17878341 1:CAS:528:DC%2BD2sXhtVCrtbbM
29. Q Xu 2008 Stem cells and transplant arteriosclerosis Circ Res 102 9 1011 1024 10.1161/CIRCRESAHA.108.171488 18467640 1:CAS:528:DC%2BD1cXltlSnsb4%3D (Pubitemid 351667855)
30. E Minami MA Laflamme JE Saffitz CE Murry 2005 Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart Circulation 112 19 2951 2958 16275883
31. EM Zeisberg O Tarnavski M Zeisberg AL Dorfman JR McMullen E Gustafsson, et al. 2007 Endothelial-to-mesenchymal transition contributes to cardiac fibrosis Nat Med 13 8 952 961 10.1038/nm1613 17660828 1:CAS:528: DC%2BD2sXos1Cjsbw%3D (Pubitemid 47222040)
32. DO Taylor LB Edwards MM Boucek EP Trulock P Aurora J Christie, et al. 2007 Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report-2007 J Heart Lung Transplant 26 8 769 781 10.1016/j.healun.2007.06.004 17692781 (Pubitemid 47199081)
33. RB Colvin 2007 Antibody-mediated renal allograft rejection: diagnosis and pathogenesis J Am Soc Nephrol 18 4 1046 1056 10.1681/ASN.2007010073 17360947 1:CAS:528:DC%2BD2sXkslSrs70%3D (Pubitemid 46536891)
34. J Wehner CN Morrell T Reynolds ER Rodriguez WM Baldwin 3rd 2007 Antibody and complement in transplant vasculopathy Circ Res 100 2 191 203 10.1161/01.RES.0000255032.33661.88 17272820 1:CAS:528:DC%2BD2sXhtVOrurw%3D (Pubitemid 46208719)
35. MP Armengol M Juan A Lucas-Martin MT Fernandez-Figueras D Jaraquemada T Gallart, et al. 2001 Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers Am J Pathol 159 3 861 873 11549579 1:CAS:528:DC%2BD3MXnt12msLo%3D
36. AE Schroder A Greiner C Seyfert C Berek 1996 Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis Proc Natl Acad Sci U S A 93 1 221 225 10.1073/pnas.93.1.221 8552609 1:STN:280:DyaK287jtl2juw%3D%3D (Pubitemid 26038131)
37. V Zarkhin L Li M Sarwal 2008 "To B or not to B?" B-cells and graft rejection Transplantation 85 12 1705 1714 10.1097/TP.0b013e318177793e 18580460
38. M Mengel J Reeve S Bunnag G Einecke B Sis T Mueller, et al. 2009 Molecular correlates of scarring in kidney transplants: the emergence of mast cell transcripts Am J Transplant 9 1 169 178 10.1111/j.1600-6143.2008.02462.x 18976290 1:STN:280:DC%2BD1M%2FmtFyjsw%3D%3D
39. K Komura K Yanaba M Horikawa F Ogawa M Fujimoto TF Tedder, et al. 2008 CD19 regulates the development of bleomycin-induced pulmonary fibrosis in a mouse model Arthritis and rheumatism 58 11 3574 3584 10.1002/art.23995 18975313 1:CAS:528:DC%2BD1cXhsV2hs7fP
40. A Yoshizaki Y Iwata K Komura F Ogawa T Hara E Muroi, et al. 2008 CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma Am J Pathol 172 6 1650 1663 10.2353/ajpath.2008. 071049 18467694 1:CAS:528:DC%2BD1cXnslKjsL4%3D (Pubitemid 351793356)
41. Z Qian W Hu J Liu F Sanfilippo RH Hruban WM Baldwin III 2001 Accelerated graft arteriosclerosis in cardiac transplants: complement activation promotes progression of lesions from medium to large arteries Transplantation 72 5 900 906 10.1097/00007890-200109150-00027 11571457 1:STN:280:DC%2BD3MritlGhtA%3D%3D
42. Z Qian CY Lee K Murata J Liu K Fox-Talbot BA Wasowska, et al. 2006 Antibody and complement mediated injury in transplants following sensitization by allogeneic blood transfusion Transplantation 82 7 857 864 10.1097/01.tp.0000232335.06792.35 17038898 (Pubitemid 44564029)
43. K Murata K Fox-Talbot Z Qian K Takahashi GL Stahl WM Baldwin III, et al. 2007 Synergistic deposition of C4d by complement and non-complement activating antibodies in cardiac transplants Am J Transpl 7 11 2605 2614 10.1111/j.1600-6143.2007.01971.x 1:CAS:528:DC%2BD2sXhtlakt73E (Pubitemid 47561614)
44. T Nozaki H Amano A Bickerstaff CG Orosz AC Novick K Tanabe, et al. 2007 Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients J Immunol 179 8 5238 5245 17911609 1:CAS:528:DC%2BD2sXhtFWitrjL
45. BA Wasowska Z Qian DL Cangello E Behrens K Van Tran JL Layton, et al. 2001 Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice Transplantation 71 727 736 10.1097/00007890-200103270-00007 11330533 1:CAS:528:DC%2BD3MXjsleqtb4%3D (Pubitemid 32377270)
46. S Rahimi Z Qian J Layton K Fox-Talbot WM Baldwin BA Wasowska 2004 Non-complement- and complement-activating antibodies synergize to cause rejection of cardiac allografts Am J Transplant 4 3 326 334 10.1111/j.1600-6143. 2004.00334.x 14961984 1:CAS:528:DC%2BD2cXivVyhtrk%3D (Pubitemid 38282287)
47. S Uehara C Chase L Cornell J Madsen P Russell R Colvin 2007 Chronic cardiac transplant arteriopathy in mice: Relationship of alloantibody, C4d deposition and neointimal fibrosis Am J Transpl 7 57 65 10.1111/j.1600-6143. 2006.01599.x 1:CAS:528:DC%2BD2sXps1Witw%3D%3D (Pubitemid 44952856)
48. PT Jindra A Hsueh L Hong D Gjertson XD Shen F Gao, et al. 2008 Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts J Immunol 180 4 2214 2224 18250428 1:CAS:528: DC%2BD1cXhsVShtb0%3D
49. CN Morrell H Sun AM Swaim WM Baldwin III 2007 Platelets, an Inflammatory Force in Transplantation Am J Transplant 7 2447 2454 10.1111/j.1600-6143.2007. 01958.x 17927608 1:CAS:528:DC%2BD2sXhtlakt7zK (Pubitemid 47561602)
50. AD Kirk CN Morrell WM Baldwin 3rd 2009 Platelets influence vascularized organ transplants from start to finish Am J Transplant 9 1 14 22 10.1111/j.1600-6143.2008.02473.x 19067663 1:STN:280:DC%2BD1M%2Fmt1yntA%3D%3D
51. Sis B, Jhangri GS, Bunnag S, Allanach K, Kaplan B, Halloran PF. Endothelial Gene Expression in Kidney Transplants with Alloantibody Indicates Antibody-Mediated Damage Despite Lack of C4d Staining. Am J Transplant 2009 (in press).
52. PS Russell CM Chase HJ Winn RB Colvin 1994 Coronary atherosclerosis in transplanted mouse hearts II. Importance of humoral immunity J Immunol 152 5135 5141 8176230 1:CAS:528:DyaK2cXksFGks7g%3D
53. H Ota K Fox-Talbot W Hu Z Qian F Sanfilippo RH Hruban, et al. 2005 Terminal complement components mediate release of von Willebrand factor and adhesion of platelets in arteries of allografts Transplantation 79 3 276 281 10.1097/01.TP.0000146195.76904.D3 15699756 1:CAS:528:DC%2BD2MXhtV2ktrw%3D (Pubitemid 40299532)
54. TK Chatterjee LL Stoll GM Denning A Harrelson AL Blomkalns G Idelman, et al. 2009 Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding Circ Res 104 4 541 549 10.1161/CIRCRESAHA.108.182998 19122178 1:CAS:528:DC%2BD1MXhvFejtL4%3D
55. RC Siow AT Churchman 2007 Adventitial growth factor signalling and vascular remodelling: potential of perivascular gene transfer from the outside-in Cardiovascular research 75 4 659 668 10.1016/j.cardiores.2007.06.007 17678883 1:CAS:528:DC%2BD2sXpt1Sku74%3D (Pubitemid 47238743)